Welcome to the HBOT News Network
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Dr. Paul Harch – The Oxygen Revolution: Hyperbaric Oxygen Therapy – Part 2
Dr. Paul Harch, a world-renowned leading expert in hyperbaric medicine joins Sound Health Radio for Part 2. Using his 30+ years of Hyperbaric Oxygen Therapy (HBOT) experience, Dr. Harch administers the most scientifically based and...
Max Minute: New Study From NYU Winthrop Hospital Suggests Hyperbaric Oxygen Therapy Could Be Alternative To Ventilator In Treating COVID-19
NEW YORK (CBSNewYork) — In the months since the first case of COVID-19 in New York, doctors have learned a tremendous amount about the virus. Perhaps most importantly is that the rush to incubate and put a patient on a ventilator was...
New Clinical Trial: Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients (HBOT)
Dr. Ory Wiesel of Maimonides Medical Center in Brooklyn, NY has begun a new clinical trial to study COVID-19 patients treated with Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients (HBOT).Brief Summary:This study is a...
Chinese Clinical Trial: Efficacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19)
According to the World Health Organization (WHO), researchers at the Sixth Medical Center of PLA General Hospital, in Bejing, China and the Wuhan Huoshenshan Hospital in Wuhan City, China have begun a clinical trial entitled, "Efficacy...
Dr. Paul Harch – The Oxygen Revolution: Hyperbaric Oxygen Therapy
Dr. Harch joins Sound Health Radio to share what his research has revealed about HBOT and how it can help those suffering from brain injury or diseases such as: stroke, autism, cerebral palsy, Alzheimer's, Parkinson's, and more! Dr....
Moscow hospital uses hyperbaric oxygenation to treat COVID-19 patients
The therapy aims to avoid artificial lung ventilation, according the hospital directorMOSCOW, June 5. /TASS/. Moscow’s Research Institute of Emergency Care (Sklifosovsky Institute) has begun experiments to use hyperbaric oxygenation...
Hyperbaric oxygen therapy for wound care being used to treat some COVID-19 patients
SHREVEPORT, La. -- Christus Health is trying something new to treat COVID-19 by using hyperbaric oxygen therapy to sustain a COVID-19 patient through oxygen deficiency.Hyperbaric oxygen therapy isn't new but, using it for this purpose...
Interview with Dr. Harch on COVID-19 on WCHV’s Joe Thomas in-the-morning
Listen to WCHV's Joe Thomas in-the-morning April 29th interview with Dr. Paul Harch on the use of Hyperbaric Oxygen Therapy, or HBOT on patients with the Spanish Flu and how it has been successfully used on COVID-19 patients today....
To Tell or Not to Tell About Encouraging Results for COVID-19 Treatments Under Investigation?
From Caroline Fife MD.comRacing to Find Better Treatments for COVID-19 PneumoniaThe COVID-19 pandemic, and the severity with which COVID-19 pneumonia has affected some patients, is spurring many clinical trials. Many (if not most) of...
Recent Hyperbaric Oxygen Therapy (HBOT) Research
New Clinical Trial: Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients (HBOT)
Dr. Ory Wiesel of Maimonides Medical Center in Brooklyn, NY has begun a new clinical trial to study COVID-19 patients treated with Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients (HBOT).Brief Summary:This study is a...
Chinese Clinical Trial: Efficacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19)
According to the World Health Organization (WHO), researchers at the Sixth Medical Center of PLA General Hospital, in Bejing, China and the Wuhan Huoshenshan Hospital in Wuhan City, China have begun a clinical trial entitled, "Efficacy...
New Clinical Trial: Compassionate Use of Hyperbaric Oxygen Therapy
Thomas E Serena, MD of the SerenaGroup, Inc. with the Wound Treatment Center at Opelousas General Hospital in Louisiana have begun a new clinical trial to study COVID-19 patients treated with Hyperbaric Oxygen Therapy under...
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT
Amir Hadanny, MD and Shai Efrati, MD of The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center (the largest hyperbaric treatment center worldwide) in Be'er Ya'akov, Israel has begun a new clinical trial to study...
Clinical Trial – Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no
specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric
Oxygen Therapy (HBOT) on 5 severe COVID-19 patients who developed respiratory insufficiency.
HBOT mechanisms of tissue oxygenation and anti-inflammatory effect may explain these
findings.
The purpose of the current study is the evaluate the efficacy of HBOT in moderate-severe
COVID-19 patients in a randomized controlled manner.
New Clinical Trial: Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) (OHB10cov)
Jean-Eric Blatteau, MD, PhD of Sainte Anne Military Teaching Hospital in Toulon, France has begun a new clinical trial to study the treatment of COVID-19 patients using Hyperbaric Oxygen Therapy. Several patients with hypoxaemic...
New Clinical Trial: Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
Dr. Jeffery S Kuo is the Lead Investigator of the latest clinical trial studying the treatment of COVID-19 patients with Hyperbaric Oxygen Therapy. The study will be based out of Ochsner Medical Center in New Orleans, Louisiana....
Clinical Trial – Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)
Several patients with hypoxaemic SARS-CoV2 pneumonia were able to benefit from hyperbaric oxygen treatment (HBOT) in China. In a clinical case published in the Chinese journal of hyperbaric medicine, treatment with repeated HBO sessions prevented admission to intensive care unit with mechanical ventilation in a patient aged 69 who presented with signs of respiratory decompensation. HBOT is the most powerful oxygenation modality in the body today. HBOT can dramatically increase the amount of dissolved oxygen in the blood. HBOT not only promotes blood transport but also its tissue delivery. Furthermore, HBOT has specific immunomodulatory properties, both humoral and cellular, making it possible, for example, to reduce the intensity of the inflammatory response and to stimulate antioxidant defenses by repeating sessions. A virucidal capacity of HBOT might also be involved. HBOT is generally regarded as safe with very few adverse events.
Clinical Trial – Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
Patients who meet inclusion criteria will be randomized into treatment vs control group.
Treatment groups will undergo Hyperbaric Oxygen Therapy (HBOT) and compared to the control
group.